We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+18.78%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.66B
AUM Growth
+$275M
Cap. Flow
+$68.7M
Cap. Flow %
4.14%
Top 10 Hldgs %
23.67%
Holding
233
New
36
Increased
109
Reduced
61
Closed
26

Top Buys

Rank Stock Value
1
WW
WW International
WW
+$23.8M
2
GLOB icon
Globant
GLOB
+$21.8M
3
PAYC icon
Paycom
PAYC
+$17.3M
4
GTLS
Chart Industries
GTLS
+$13.6M
5
SODA
SodaStream International Ltd
SODA
+$12.4M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$10.8M
2
ULTI
Ultimate Software Group Inc
ULTI
+$9.84M
3
MB
MINDBODY, Inc. Class A Common Stock
MB
+$9.71M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$9.52M
5
AXON
Axon Enterprise
AXON
+$9.38M

Sector Composition

Rank Sector Weight
1 Technology 32.93%
2 Healthcare 19.82%
3 Industrials 15.24%
4 Consumer Discretionary 9.82%
5 Consumer Staples 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLAB icon
151
Silicon Laboratories
SLAB
$7.23B
$2.43M 0.15%
24,361
+4,062
+20% +$406K
MPWR icon
152
Monolithic Power Systems
MPWR
$68.9B
$2.42M 0.15%
18,126
+2,804
+18% +$357K
CDTX
153
DELISTED
Cidara Therapeutics
CDTX
$2.37M 0.14%
+22,800
New +$2.15M
CTG
154
DELISTED
Computer Task Group, Inc.
CTG
$2.34M 0.14%
302,467
+41,384
+16% +$315K
ZAGG
155
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$2.3M 0.14%
132,901
-90,215
-40% -$1.3M
VCEL icon
156
Vericel Corp
VCEL
$2.31B
$2.29M 0.14%
+236,616
New +$2.95M
SPRO icon
157
Spero Therapeutics
SPRO
$73M
$2.22M 0.13%
+151,148
New +$1.93M
BGC icon
158
BGC Group
BGC
$4.89B
$2.17M 0.13%
298,229
+94,362
+46% +$754K
IMPV
159
DELISTED
Imperva, Inc.
IMPV
$2.17M 0.13%
44,961
+2,425
+6% +$116K
VIVE
160
DELISTED
VIVEVE MED INC
VIVE
$2.16M 0.13%
793
+429
+118% +$1.24M
APPS icon
161
Digital Turbine
APPS
$1.74B
$2.11M 0.13%
1,400,126
+825,915
+144% +$1.42M
HDSN
162
Hudson Technologies
HDSN
$235M
$2.08M 0.13%
1,035,117
+669,745
+183% +$2.17M
ZS icon
163
Zscaler
ZS
$27.3B
$2.08M 0.13%
58,162
-38,788
-40% -$1.18M
SGMO
164
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.01M 0.12%
141,348
+11,993
+9% +$199K
MLNT
165
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$1.93M 0.12%
+60,838
New +$2.19M
FNSR
166
DELISTED
Finisar Corp
FNSR
$1.93M 0.12%
106,954
+13,656
+15% +$226K
ENSV
167
DELISTED
Enservco Corp.
ENSV
$1.9M 0.11%
109,072
+3,308
+3% +$55.4K
NMRK icon
168
Newmark Group
NMRK
$2.63B
$1.88M 0.11%
131,939
+94,595
+253% +$1.39M
PRTK
169
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.8M 0.11%
+176,538
New +$2M
IPHI
170
DELISTED
INPHI CORPORATION
IPHI
$1.73M 0.1%
52,945
+14,090
+36% +$460K
TRUP icon
171
Trupanion
TRUP
$1.18B
$1.6M 0.1%
41,501
-67,200
-62% -$2.09M
SUPN icon
172
Supernus Pharmaceuticals
SUPN
$2.77B
$1.58M 0.1%
26,389
-45,600
-63% -$2.36M
THO icon
173
Thor Industries
THO
$4.14B
$1.47M 0.09%
15,093
+2,989
+25% +$305K
CDNS icon
174
Cadence Design Systems
CDNS
$93.4B
$1.41M 0.09%
32,614
+1,434
+5% +$59K
BLFS icon
175
BioLife Solutions
BLFS
$1.7B
$1.36M 0.08%
+119,274
New +$1.09M
5 6
7
8 9

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Granahan Investment Management held 233 positions worth $1.66B, up 20% from $1.38B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Granahan Investment Management deployed $68.7M of net new capital in Q2 2018, opening 36 new positions and adding to 109 existing holdings. Its largest new stake was Globant: 437,078 shares worth $24.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Teladoc Health, an estimated $10.8M trimmed.

  • Granahan Investment Management's largest Q2 2018 buy was Globant: 437,078 shares worth $24.8M.
  • Granahan Investment Management added most to WW International in Q2 2018, an estimated $23.8M increase.
  • Granahan Investment Management's biggest Q2 2018 reduction was Teladoc Health, cutting an estimated $10.8M.
  • Granahan Investment Management fully exited MINDBODY, Inc. Class A Common Stock in Q2 2018, selling an estimated $9.71M.
  • Granahan Investment Management's ten largest holdings make up 24% of its $1.66B portfolio in Q2 2018.
  • Granahan Investment Management opened 36 new positions and closed 26 in Q2 2018.
  • Granahan Investment Management's portfolio value rose 20% quarter-over-quarter to $1.66B.

Based on Granahan Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.